105 related articles for article (PubMed ID: 21671019)
1. Polymorphisms of matrix metalloproteinases (MMP) gene and breast cancer risk: appraisal of a recent meta-analysis.
Wu XY; Chen MB; Wang LQ; Xu Y; Tan Y; Shen WX
Breast Cancer Res Treat; 2011 Nov; 130(1):357-8. PubMed ID: 21671019
[No Abstract] [Full Text] [Related]
2. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-9 -1562T allele and its combination with MMP-2 -735 C allele are risk factors for breast cancer.
Rahimi Z; Yari K; Rahimi Z
Asian Pac J Cancer Prev; 2015; 16(3):1175-9. PubMed ID: 25735351
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype.
Grieu F; Li WQ; Iacopetta B
Breast Cancer Res Treat; 2004 Dec; 88(3):197-204. PubMed ID: 15609121
[TBL] [Abstract][Full Text] [Related]
5. Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis.
Liu D; Guo H; Li Y; Xu X; Yang K; Bai Y
PLoS One; 2012; 7(2):e31251. PubMed ID: 22348060
[TBL] [Abstract][Full Text] [Related]
6. Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kim HJ; Park CI; Park BW; Lee HD; Jung WH
Yonsei Med J; 2006 Jun; 47(3):333-42. PubMed ID: 16807982
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of associations between four polymorphisms in the matrix metalloproteinases gene and gastric cancer risk.
Yang TF; Guo L; Wang Q
Asian Pac J Cancer Prev; 2014; 15(3):1263-7. PubMed ID: 24606450
[TBL] [Abstract][Full Text] [Related]
8. Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP) gene and breast cancer risk: a meta-analysis.
Zhou P; Du LF; Lv GQ; Yu XM; Gu YL; Li JP; Zhang C
Breast Cancer Res Treat; 2011 Jun; 127(3):813-8. PubMed ID: 21161369
[TBL] [Abstract][Full Text] [Related]
9. No evidence indicated that polymorphisms of the matrix metalloproteinases genes were associated with breast cancer risk: an update.
He T
Breast Cancer Res Treat; 2011 Jul; 128(2):589-91. PubMed ID: 21336947
[No Abstract] [Full Text] [Related]
10. Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases.
Ye S
Matrix Biol; 2000 Dec; 19(7):623-9. PubMed ID: 11102751
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects.
McColgan P; Sharma P
Int J Cancer; 2009 Sep; 125(6):1473-8. PubMed ID: 19507256
[TBL] [Abstract][Full Text] [Related]
12. CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk.
Lei H; Sjöberg-Margolin S; Salahshor S; Werelius B; Jandáková E; Hemminki K; Lindblom A; Vorechovský I
Int J Cancer; 2002 Mar; 98(2):199-204. PubMed ID: 11857408
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study.
Slattery ML; John E; Torres-Mejia G; Stern M; Lundgreen A; Hines L; Giuliano A; Baumgartner K; Herrick J; Wolff RK
PLoS One; 2013; 8(5):e63165. PubMed ID: 23696797
[TBL] [Abstract][Full Text] [Related]
14. The Association of
Hsiao CL; Liu LC; Shih TC; Lai YL; Hsu SW; Wang HC; Pan SY; Shen TC; Tsai CW; Chang WS; Su CH; Way TD; Chung JG; Bau DT
In Vivo; 2018; 32(3):487-491. PubMed ID: 29695550
[TBL] [Abstract][Full Text] [Related]
15. Lack of an association between matrix metalloproteinase polymorphisms and coronary heart disease in a Han Chinese population.
Wang CM; Ye HD; Li YR; Hong QX; Tang LL; Zhou AN; Xu MQ; Duan SW
Genet Mol Res; 2015 Oct; 14(4):12254-61. PubMed ID: 26505374
[TBL] [Abstract][Full Text] [Related]
16. Current evidence on the relationships among five polymorphisms in the matrix metalloproteinases genes and prostate cancer risk.
Gui J; Zhou H; Li S; Chen A; Liu Q; Zhu L; Mi Y
Sci Rep; 2024 May; 14(1):11355. PubMed ID: 38762659
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer.
Dos Reis ST; Pontes J; Villanova FE; Borra PM; Antunes AA; Dall'oglio MF; Srougi M; Leite KR
J Urol; 2009 May; 181(5):2320-5. PubMed ID: 19303106
[TBL] [Abstract][Full Text] [Related]
18. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L
Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818
[TBL] [Abstract][Full Text] [Related]
20. Type I collagen and matrix metalloproteinase 1, 3 and 9 gene polymorphisms in the predisposition to pelvic organ prolapse.
Ferrari MM; Rossi G; Biondi ML; Viganò P; Dell'utri C; Meschia M
Arch Gynecol Obstet; 2012 Jun; 285(6):1581-6. PubMed ID: 22210296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
